1095 related articles for article (PubMed ID: 8381269)
1. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
[TBL] [Abstract][Full Text] [Related]
2. Detection of serum hepatitis C virus RNA in HCV antibody-seropositive volunteer blood donors.
McGuinness PH; Bishop GA; Lien A; Wiley B; Parsons C; McCaughan GW
Hepatology; 1993 Sep; 18(3):485-90. PubMed ID: 7689526
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay.
Zanella A; Conte D; Prati D; Mozzi F; Capelli C; Zanuso F; Fraquelli M; Bosoni P; Vianello L; Pappalettera M
Hepatology; 1995 Apr; 21(4):913-7. PubMed ID: 7535737
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test.
Serfaty L; Nousbaum JB; Elghouzzi MH; Giral P; Legendre C; Poupon R
Hepatology; 1995 Mar; 21(3):725-9. PubMed ID: 7875670
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to hepatitis C virus and hepatitis C virus RNA in Chinese blood donors determined by ELISA, recombinant immunoblot assay and polymerase chain reaction.
Zhang YY; Guo LS; Hao LJ; Hansson BG; Widell A; Nordenfelt E
Chin Med J (Engl); 1993 Mar; 106(3):171-4. PubMed ID: 7686839
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease].
Sakashita H
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs.
Pereira BJ; Milford EL; Kirkman RL; Quan S; Sayre KR; Johnson PJ; Wilber JC; Levey AS
N Engl J Med; 1992 Sep; 327(13):910-5. PubMed ID: 1325035
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of antibodies to hepatitis C virus in relation to surrogate markers in a blood donor population of Singapore.
Kuperan P; Choon AT; Ding SH; Lee G
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():127-9. PubMed ID: 7533946
[TBL] [Abstract][Full Text] [Related]
9. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey.
Serfaty L; Giral P; Elghouzzi MH; Jullien AM; Poupon R
Hepatology; 1993 Feb; 17(2):183-7. PubMed ID: 8381381
[TBL] [Abstract][Full Text] [Related]
11. Testing for HCV markers.
Reesink HW; van der Poel CL; Bresters D; Cuypers HT; Zaaijer H; Lelie PN
Dev Biol Stand; 1993; 81():77-84. PubMed ID: 7513661
[TBL] [Abstract][Full Text] [Related]
12. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
[TBL] [Abstract][Full Text] [Related]
13. Analysis of ELISA hepatitis C virus-positive blood donors population by polymerase chain reaction and recombinant immunoblot assay (RIBA). Comparison of second and third generation RIBA.
Chicheportiche C; Cantaloube JF; Biagini P; Aumont P; Donnadieu F; Escher J; Larabi F; Zepitelli JP
Acta Virol; 1993; 37(2-3):123-31. PubMed ID: 7692714
[TBL] [Abstract][Full Text] [Related]
14. [Second generation hepatitis-C virus test and polymerase chain reaction in anti-C 100 negative patients with chronic non-A, non-B hepatitis].
Zala G; Havelka J; Wicki AN; Joller-Jemelka HI; Meier B; Schmid M; Bühler H
Schweiz Med Wochenschr; 1992 Mar; 122(11):363-8. PubMed ID: 1313601
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of antibodies to hepatitis C virus and other markers in Jamaica.
King SD; Dodd RY; Haynes G; Wynter HH; Sullivan MT; Serjeant GR; Choo-Kang E; Michael E
West Indian Med J; 1995 Jun; 44(2):55-7. PubMed ID: 7545339
[TBL] [Abstract][Full Text] [Related]
16. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
Chung HT; Lee JS; Lok AS
Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
[TBL] [Abstract][Full Text] [Related]
17. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied.
Espinosa M; Martin-Malo A; Alvarez de Lara MA; Soriano S; Aljama P
Clin Nephrol; 2000 Aug; 54(2):151-6. PubMed ID: 10968693
[TBL] [Abstract][Full Text] [Related]
18. [Enzyme-linked immunosorbent assay for antibodies against core protein of hepatitis C virus with a synthetic oligopeptide].
Sugiyasu T
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):148-58. PubMed ID: 7686127
[TBL] [Abstract][Full Text] [Related]
19. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.
Ahmad N; Asgher M; Shafique M; Qureshi JA
Saudi Med J; 2007 Mar; 28(3):390-5. PubMed ID: 17334466
[TBL] [Abstract][Full Text] [Related]
20. Significance of specific antibody assay for genotyping of hepatitis C virus.
Tanaka T; Tsukiyama-Kohara K; Yamaguchi K; Yagi S; Tanaka S; Hasegawa A; Ohta Y; Hattori N; Kohara M
Hepatology; 1994 Jun; 19(6):1347-53. PubMed ID: 7514558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
